NINDS Neuroscience Funding Announcements

Funding Resources
Funding Overview
Funding Strategy

Funding Opportunities

Grant Mechanisms
Training & Career
Development
Contracts Management
Review Committees
Funding News
Program Areas

Research
Anticonvulsant Screening
   Program
Clinical Research
Counterterrorism
Epilepsy Research Web
Neural Interfaces Program
NIH Roadmap Research
Parkinson's Web
Resources for Scientists
Stem Cell Research
Translational Research
Traumatic Brain Injury
   (TBI) Research
Technology Transfer
   Office

NINDS is part of the
National Institutes of
Health

Download Adobe Reader

Print-friendly version

Email this page

Application processes at NIH are changing. Applicant organizations are encouraged to start preparing for this transition by registering with Grants.gov and NIH eRA Commons now.

Translational Research in Muscular Dystrophy (U01)
Release Date: November 30, 2005
Announcement Number: PAR-06-044
Application Receipt Date:
February 1, 2006
June 1, 2006
October 1, 2006
February 5, 2007
June 5, 2007
October 5, 2007
February 5, 2008
June 5, 2008
October 5, 2008

Funding Contact: John Porter, Ph.D.
Program Area: Channels, Synapses and Neural Circuits
Also See: http://grants.nih.gov/grants/guide/notice-files/NOT-NS-06-010.html

Brief Description:
The National Institute of Neurological Disorders and Stroke and the National Institute of Arthritis and Musculoskeletal and Skin Diseases solicit applications for translational research projects in muscular dystrophy. Several emerging pathways to treatment of muscular dystrophy show promise, ranging from palliative therapies that can markedly delay onset or progression of the disease to genetic or stem cell approaches that may reverse or eliminate the condition. The objective of this initiative is to encourage the pursuit of a broad range of translational research strategies for therapeutic development in muscular dystrophy. This Program Announcement (PA) solicits applications for cooperative agreements that will support milestone-driven projects focused on the identification and pre-clinical in vitro or animal testing of new therapeutics. Applications are encouraged for translational research projects for any one or more of the muscular dystrophies.

Choose an option to view additional funding announcements